Report : North America Optical Coherence Tomography Angiography Equipment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Tabletop Type and Handheld Type) and End User (Hospitals, Clinics, and Others)
The hospitals segment by end user is estimated to lead the market growth during the forecast period.
According to a new market research study of “North America Optical Coherence Tomography Angiography Equipment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type, End User and Country.” The North America optical coherence tomography angiography equipment market is expected to reach US$ 360.54 million by 2028 from US$ 223.74 million in 2021; it is estimated to grow at a CAGR of 7.1% from 2021 to 2028. The report highlights trends prevailing in the North America optical coherence tomography angiography equipment market and the factors driving market along with those that act as hindrances.
Eye-related conditions and disorders include diabetic retinopathy, glaucoma, age-related macular degeneration, ocular histoplasmosis, retinal vein occlusion, and retinal breaks and detachment. Diabetic retinopathy (DR) is caused due to high blood sugar levels that damage blood vessels of the retina or cause changes to them. These changes may include swelling, leakage, or closing, thus stopping the passage of the blood. In some people, abnormal new blood vessels grow on the surface of the retina. Such changes to the retina can hamper the vision of a person. According to the NCBI article, the number of adults with DR is expected to grow from ~103.12 million in 2020 to ~160.50 million by 2045 in the world. In addition, the DR is the most common diabetic eye disease and a leading cause of blindness among US adults. As per the National Eye Institute data, the number of Americans with DR is expected to double, from 7.7 million in 2010 to 14.6 million by 2050. With more than 150 million people estimated to be living with diabetes by 2040, the number of people suffering from diabetic retinopathy and vision impairment is also expected to rise in the future.
Glaucoma, ranked as the second-leading cause of blindness globally, damages the eye’s optic nerve. According to the National Glaucoma Research data, the number of people suffering from glaucoma is projected to grow from ~80 million in 2020 to ~111 million by 2040 in United States. It is also the leading cause of irreversible blindness in the US as more than 3 million Americans are likely to be suffering from glaucoma. Among various causes of total blindness in adults, glaucoma caused 11.0% of blindness across the world in 2020, followed by diabetic retinopathy with 2.5% cases.
The optical coherence tomography (OCT) angiography helps in the evaluation of various ophthalmologic diseases, such as diabetic retinopathy, age-related macular degeneration (AMD), and retinal vascular occlusions, by providing a detailed view of the retinal vasculature that allows accurate delineation of abnormalities in diabetic eyes and vascular occlusions. It helps quantify vascular compromise depending on the severity of diabetic retinopathy. The OCT angiography can aid visibility in microaneurysms and retinal nonperfusion areas, enabling closer observation of each layer of retinal capillaries. It also evaluates the microvascular status and effectiveness of DR treatments. Hence, a rise in the prevalence of eye-related diseases boosts the adoption of OCT devices in hospitals and imaging centers, thereby driving the optical coherence tomography angiography equipment market growth.
The North America optical coherence tomography angiography equipment market, based on type, has been bifurcated into handheld type and tabletop type. The market, based on end user, is segmented into hospitals, clinics, and others. In terms of country, the North America optical coherence tomography angiography equipment market is segmented into the US, Canada, and Mexico.
NIDEK CO.; LTD, Carl Zeiss AG’; Optovue Incorporated; Canon Inc.; OPTOPOL Technology Sp. z o.o; Michelson Diagnostics Ltd.; SANTEC CORPORATION; Alcon Inc.; Topcon Corporation; and Heidelberg Engineering GmbH are among the leading companies operating in the North America optical coherence tomography angiography equipment market.
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org